Orchid Pharma consolidated Q2 FY24 net profit up at Rs. 19.80 Cr
News

Orchid Pharma consolidated Q2 FY24 net profit up at Rs. 19.80 Cr

Orchid Pharma reported total income of Rs. 207.11 crores during the period ended September 30, 2023

  • By IPP Bureau | November 06, 2023

Orchid Pharma Limited has reported consolidated financial results for the period ended September 30, 2023.

Orchid Pharma has posted net profit of Rs. 19.80 crores for the period ended September 30, 2023 as against net profit of Rs. 9.40 crores for the period ended June 30, 2023. The company posted net profit loss of Rs. 5.39 crores for the period ended September 30, 2022.

Orchid Pharma reported total income of Rs. 207.11 crores during the period ended September 30, 2023 as compared to Rs. 184.80 crores during the period ended June 30, 2023. The company reported total income of Rs.171.08 crores during the period ended September 30, 2022. 

For the Half Year ended September 30, 2023, Orchid Pharma has reported total income of Rs.391.91  crores as compared to Rs.305.00 crores during the 6 Months period ended September 30, 2022.

The company has posted net profit of Rs.29.20 crores for the 6 Months period ended September 30, 2023 as against net profit of Rs.-20.40 crores for the 6 Months period ended September 30, 2022.

Upcoming E-conference

Other Related stories

Startup

Digitization